Infectious Disease Therapeutics Market Market Size

Infectious Disease Therapeutics Market size is estimated at USD 124.5 billion in 2024 and is predicted to reach USD 188.1 billion by the end of 2037, expanding at around 3.5% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of infectious disease therapeutics is evaluated at USD 128.8 billion.

The infectious disease therapeutics market is witnessing significant growth lately, due to the rising prevalence of various infectious diseases, advancements in therapeutics treatments, and medical research. The consistent development in this field is driven by evolving trends such as gene editing technologies, immunotherapy combinations, nano-technology-based delivery systems, personalized consultations, and artificial intelligence-derived treatments. Genetically diverse populations across the globe are providing a significant opportunity for researchers, clinicians, and healthcare professionals to develop a precise healthcare framework with effective therapy interventions by leveraging genetic data and insights. Government agencies, pharmaceutical companies, and research institutions are striving together to explore advancement in the therapeutics field and address the global burden of infectious diseases.